1 / 17

Hodgkin's lymphoma

Hodgkin's lymphoma. Louise Gribben Haematology CNS HAI 2016. Case study. 61 year old female HD on ABVD chemotherapy 6 th and final ABVD 9 th October Help line call same day Pyrexia, rigors ?bleomycin reaction Developed hacking cough, hypoxic Not neutropenic. …. …. …. ….

cathleenr
Download Presentation

Hodgkin's lymphoma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hodgkin's lymphoma Louise Gribben Haematology CNS HAI 2016

  2. Case study • 61 year old female • HD on ABVD chemotherapy • 6th and final ABVD 9th October • Help line call same day • Pyrexia, rigors ?bleomycin reaction • Developed hacking cough, hypoxic • Not neutropenic

  3. Deterioration over 1 week • Broad spectrum anti bacterials • Increasing SOB • No evidence for infective process • Increasing oxygen requirements • High dose Co-trimoxazole/steroids

  4. ICU (day 7 post admission) • Type 1 respiratory failure/ fibrotic changes • Intubated/ ventilated • Probable BIP • Deceased ( day 18 post admission)

  5. Bleomycin Induced Pneumonitis and Fibrosis Duggan et al 2003 28% of HD ĉ ABVD 224 of 814 patients Martin et al 2005 18% of HD ĉ ABVD 25 of 141 patients 5 died

  6. Side effects • Fever, chills, hypotension • Dermal pigmentation, fibrosis • Stomatitis • Fatigue • Pulmonary toxicity • Bronchiolitis obliterans with organizing pneumonia • Interstitial pneumonitis with progression to fibrosis • Death – 3%

  7. BIP – Clinical Features Initial • Non productive cough • Exertional dyspnoea • Sometimes fever Progressive • Dyspnoea at rest • Tachynoea • Cyanosis On examination – fine basal creps, progress to rhonchi sometimes pleural rub

  8. Treatment • Exclude infection • Corticosteroid • Stop Bleomycin • In survivors, pulmonary symptoms and lung function normalise in time

  9. Adjusted management • Specific ABVD prescription charts. • Drug specific counselling/consent forms. • Pre chemo exercise/oximetry testing • Repeated PFT pre each treatment after cycle 3 • Avoid use of GCSF products • Caution with O2 therapy

  10. In Future Avoid/ Reduce Bleomycin in regimen Nice guidance PET scan can distinguish active inflammation and lung damage

More Related